-
-
FDA approves ONGENTYS® ▼ (opicapone)
-
23rd May 2020
-
Posted in Industry News
- News from Bial
-
-
From the Co-Editor
-
19th May 2020
-
Posted in Editor's introduction
- Universally, like many writers, I can only begin by expressing my deep shock at the worldwide impact of COVID-19 and also by offering deep...
-
-
Neurodiem, a new digital platform of independent, high-quality scientific content for UK neuro practitioners
-
14th May 2020
-
Posted in Industry News
- News from Biogen Inc.
-
-
BNA Journal Indexing
-
13th May 2020
-
Posted in Industry News
- News from the British Neuroscience Association
-
-
Preparing for the storm: impact of the COVID-19 pandemic on rehabilitation services
-
7th May 2020
-
Posted in Comment,COVID-19 Articles,Rehabilitation Articles,Special Feature
- Fahim Anwar, Judith Allanson, Katie Bond, Emer McGilloway and Harry Mee.
-
-
More than a number; the limitations of the Clinical Frailty Scale for patient escalation decision making in COVID-19
-
5th May 2020
-
Posted in Comment,COVID-19 Articles,Rehabilitation Articles,Special Feature
- Stephen Halpin and Alice Jundi
-
-
EAN Annual Congress goes virtual
-
28th Apr 2020
-
Posted in Courses & Conferences
- News of the EAN Annual Congress
-
-
First super-resolution image of tiny brain receptor could give scientists a better understanding of Parkinson’s and Alzheimer’s
-
16th Apr 2020
-
Posted in Industry News,Neurology News
- Academic news from University of Birmingham
-
-
CLINICAL VIEWPOINT: Immunosuppression and COVID-19
-
15th Apr 2020
-
Posted in Clinical Review Article,Comment,COVID-19 Articles,Online First,Special Feature
- Clinical viewpoint from Gavin Giovannoni
